Neuberg Diagnostics and OptraSCAN® announces the launch of Global TELEPath™ Network in UAE, India and South Africa through a Joint venture.
The new venture “Neuberg DIGIPATH, Powered by OptraSCAN® Inc.” will focus on providing advanced and affordable digital pathology solutions.
Dubai, 5th February 2019: Neuberg Diagnostics Pvt. Ltd., one of the top 4 diagnostics service providers in India and OptraSCAN® Inc., the US-based global digital pathology solutions provider today announced launching of Global TELEPath™ Network for the pathologist community in UAE, India and South Africa under a new joint venture namely, “Neuberg DIGIPATH, Powered by OptraSCAN®Inc.” The joint venture is in its initial phase and will be formed in three months. The announcement was made at the annual event for the international medical laboratory community, MedLab 2019 in Dubai, United Arab Emirates. The Global TELEPath™ Network, promoted by OptraSCAN was launched in US and European region last year.
The joint venture combines the exceptional histopathology and cytology services provided by Neuberg Diagnostics Network with advanced digital pathology capabilities offered by OptraSCAN and brings to the table a whole new array of services related to digitization of tissue slides and telepathology with an objective of making new-age life-saving healthcare technology available to humankind. The joint venture promises access to a large pool of histopathologists – who diagnose and study diseases using expert medical interpretation of cells and tissue samples – from UAE, India and South Africa. Histopathology is, among other applications, integral to cancer management through the staging and grading of tumours.
“Neuberg’s vision has always been to deploy the most advanced technologies assisted by data science and artificial intelligence tools. This has brought some of the best pathologists, biochemists, geneticists, microbiologists and several other clinical lab professionals from around the world to work closely, sharing knowledge and using the latest generation of diagnostics techniques”, said Dr. GSK Velu, Founder & Chairman, Neuberg Diagnostics. “With OptraSCAN’s expertise in providing new-age technology that is well-equipped with AI & ML based analysis tools, the newly combined organization will enable us to expand the service as well as the geographic reach of Neuberg's existing lab services. We expect the economies of scale from this partnership to help us bring better value to our clients and expand our service offerings.”
This new venture ‘Neuberg DIGIPATH, Powered by OptraSCAN® Inc.’ services comprise of digitization of tissue slides, storage and archiving, slide discussions and digital learning modules, automated slide processing platforms and second-opinion tele-consulting services. Apart from user-friendly features like a compact, high-resolution and cloud-ready platform with smart-recognition facilities, the new entity promises an economically priced “walk-away technology” for the healthcare sector. The partners intend to provide labs with cutting-edge technology using the following products and services
“We are delighted to be partnering with Neuberg Diagnostics. This new venture, ‘Neuberg DIGIPATH, Powered by OptraSCAN® Inc.’, is the next step forward in a healthcare collaboration that combines the expertise and capabilities of OptraSCAN with Neuberg Diagnostics to provide advanced and affordable digital pathology products in India, Middle East, Africa and beyond,” said Mr. Abhi Gholap, Founder & CEO, OptraSCAN. “OptraSCAN’s Global TELEPath™ Network has great market traction in USA and European region, so this venture is also a part of our global strategy to create innovative healthcare affiliations with leading healthcare providers around the globe to enhance our reach in untapped regions.”
Through this partnership joint venture, both the companies aim to expand their market base and have planned a phase and region-wise expansion. In phase-I, the joint venture intends to launch its products and services in UAE, India and South Africa; followed by Phase-II, wherein it hopes to expand their offerings to rest of Asia, Europe and Africa. The joint venture partners intend to make on-demand cutting-edge digital pathology solutions available to leading hospitals in the Middle East region thus taking healthcare and diagnostics deep into the digital age.
“Digital pathology – the futurescape of pathology opens up new vistas to daily reporting, expert opinions, peer consults, quality assessment, storage and artificial intelligence. NEUBERG DIGIPATH builds bridges along this journey with complete digital pathology solutions” says Dr. Jayaram, the Head of Histopathology & Cytology Services of Neuberg Diagnostics network.
When three large medical laboratory chains of repute in India, one in South Africa and one in the United Arab Emirates decided to come together under one organization and pool their combined history of 200 years and their annual experience of dealing with 20 million medical samples annually, the Neuberg Diagnostics was born in October 2017. Within one year of its inception Neuberg has become one of the top four diagnostics companies of Indian origin with comprehensive presence across India, UAE and South Africa. The network is now being expanded to other parts of Middle East / Africa along with upcoming laboratories in USA/ Europe too.
What Neuberg brings to the medical world is the combined strength of the labs to perform over 5,000 varieties of investigations and to promote prevention and early diagnosis, focused wellness programmes and structured disease management programs for rare diseases using the most advanced technologies assisted by data science and artificial intelligence tools. This has brought some of the best pathologists, biochemists, geneticists, microbiologists and several other clinical lab professionals from around the world to work closely, sharing knowledge and using the latest generation of diagnostics techniques such as molecular diagnostics, genomics, proteomics, metabolomics and digital pathology.
An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN® has developed the world’s first ‘On-Demand Digital Pathology’ system; focused on delivering fully integrated, affordable systems and solutions. These serve as the perfect tool for transition from conventional microscopy to digital pathology for the effective acquisition of whole slide images, viewing, storing, real time sharing, and reporting via on-demand or outright purchase model.
San Jose, CA based OptraSCAN’s Digital Pathology system comprises of 15-slides small-footprint, low and high throughput WSI scanners that are well equipped for brightfield application; an integrated image viewer and image management system - IMAGEPath®, image analysis - OptraASSAYS™, a cloud-based LIMS - CLOUDPath®, and CARDS™ (computer aided region detection system). OptraSCAN’s integrated solutions include TELEPath™, a comprehensive telepathology solution and AI & ML- based automated image analysis solutions that have been developed to provide accurate assessment of nuclear and membrane biomarker, immuno-oncology and prostate cancer. Follow Us on LinkedIn and Twitter
Web-based Image Management and Viewing
Digital Pathology That’s More Collaborative
Web and Mobile Digital Conferencing
Laboratory Information Management System
On-demand image analysis
Have questions about our products, support services, or anything else?
Let us know and we’ll get back to you.